Consultations may be synchronous (video) or asynchronous (messaging) depending on state law, patient profile, and medication type
It starts with our strict sourcing guidelines
Smad2 and 3 transcription factors control muscle mass in adulthood
Filed Under: Biologics, Dermatology, Immunology, Infectious Disease, Metabolic disease/endicrinology, Oncology Tagged With: AbbVie, biologic drugs, biosimilar competition, drug sales H1 2025, Eli Lilly, GLP-1 drugs, IL-23 inhibitors, immunology drugs, Keytruda patent expiry, loss of exclusivity, Merck, Novo Nordisk, obesity drugs, Oncology Therapeutics, patent cliff 2028, PD-1 inhibitors, pharmaceutical blockbusters, prescription drug market, Skyrizi, therapeutic categories Brian Buntz As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology
Topical minoxidil (2-5%) can be used safely alongside retatrutide and may help prevent or minimize telogen effluvium
It's just not OK
